本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Oncternal Therapeutics, Inc.

0.5266
0.0000
成交量:- -
成交額:- -
市值:155.85萬
市盈率:-0.05
高:0.5266
開:0.5266
低:0.5266
收:0.5266
52周最高:0.5266
52周最低:0.5266
股本:295.96萬
流通股本:270.64萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-11.6916
每股收益(LYR):-13.4282
淨資產收益率:-149.86%
總資產收益率:-74.11%
市淨率:0.17
市盈率(LYR):-0.04

資料載入中...

2021/03/11

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/11

重要事件披露

8-K - Current report
2021/03/01

重要事件披露

8-K - Current report
2021/02/17

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/28

重要事件披露

8-K - Current report
2020/12/18

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/12/18

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/11

重要事件披露

8-K - Current report
2020/12/10

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/12/10

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/12/07

重要事件披露

8-K - Current report
2020/11/19

重要事件披露

8-K - Current report
2020/11/18

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/11/17

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/11/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/04

重要事件披露

8-K - Current report
2020/08/31

重要事件披露

8-K - Current report
2020/08/28

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses